Biolegend, 368512, APC anti-human CD45 Antibody, 100tests

CD45 is a 180 - 240 kD single chain type I membrane glycoprotein also known as leukocyte common antigen (LCA) and T200. It is a tyrosine phosphatase expressed on the plasma membrane of all hematopoietic cells, except erythrocytes or platelets. CD45 is a signaling molecule that regulates a variety of cellular processes including cell growth, differentiation, cell cycle, and oncogenic transformation. CD45 plays a critical role in T and B cell antigen receptor-mediated activation by dephosphorylating substrates including p56Lck, p59Fyn, and other Src family kinases. CD45 non-covalently associates with lymphocyte phosphatase-associated phosphoprotein (LPAP) on T and B lymphocytes. CD45 has been reported to bind galectin-1 and to be associated with several other cell surface antigens including CD1, CD2, CD3, and CD4.
100tests
Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: Human PBMC
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Red Laser (633 nm)
Application Notes: It was found that the HI30 clone and the 2D1 clone can cross block each other's binding.
Application References(PubMed link indicates BioLegend citation): Bradstock KF, et al. 1980. J. Natl. Cancer Inst. 65:33. Csiba A, et al. 1984. Br. J. Cancer 50:699. Tchilian EZ, et al. 2001. J. Immunol. 166:1308. Lee MS, et al. 2004. Int. Immunol. 16:1109.
Product Citations: Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed Lee CW, et al. 2022. J Adv Res. 39:73. PubMed Park J, et al. 2022. Bone Joint Res. 11:777. PubMed Campbell KA, et al. 2023. Commun Biol. 6:264. PubMed Govaerts I, et al. 2021. J Hematol Oncol. 14:97. PubMed Voit RA, et al. 2023. Nat Immunol. 24:69. PubMed Issa N, et al. 2023. Leukemia. :. PubMed Boyd DF, et al. 2020. Nature. 587:466. PubMed Galán-Díez M, et al. 2022. Cancer Discov. . PubMed Marinaccio C, et al. 2021. Cancer Discovery. 11(6):1398-1410. PubMed Jiang S, et al. 2021. Bioact Mater. 2711:6. PubMed Azizi E et al. 2018. Cell. 174(5):1293-1308 e36. PubMed Kim JT, et al. 2022. Nat Commun. 13:121. PubMed Antonucci L, et al. 2020. Journal of Immunology Research. 3257.929861. PubMed Hansen IS, et al. 2018. Nat Commun. 9:863. PubMed Liu S, et al. 2021. Mol Ther. 29:1918. PubMed Choi J, et al. 2021. Nat Cell Biol. 23:953. PubMed Celik H, et al. 2021. Cancer Discov. 11:3126. PubMed Chen D, et al. 2021. Molecular Cell. 81:3833. PubMed Gao P, et al. 2017. Cytotechnology. 69:751. PubMed Qian SJ, et al. 2021. Front Immunol. 12:711337. PubMed Li J, et al. 2021. Mol Med Rep. 1:23. PubMed Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed Sun J et al. 2018. Cell stem cell. 23(3):355-369 . PubMed Yoshida R, et al. 2022. Cancer Res. :. PubMed Lee JK, et al. 2021. Cells. 10:. PubMed Celik H, et al. 2018. Cancer Cell. 34:741. PubMed Lin KH, et al. 2020. Nat Genet. 52:408. PubMed Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed Dou D, et al. 2016. Nat Cell Biol. 18: 595-606. PubMed Wang J, et al. 2020. Cell Stem Cell. 27(1):81-97. PubMed Yang X, et al. 2020. Immunity. 51(6):983-996.e6.. PubMed Mahajan A, et al. 2019. J Leukoc Biol. 105:1087. PubMed Chijimatsu R, et al. 2022. Regen Ther. 21:52. PubMed
RRID: AB_2566371 (BioLegend Cat. No. 368511) AB_2566372 (BioLegend Cat. No. 368512)
Structure: Type I transmembrane protein, 180 - 240 kD (multiple isoforms)
Distribution: Hematopoietic cells, except circulating erythrocytes or platelets.
Function: Tyrosine phosphatases, signaling, co-stimulation (co-inhibition), TCR and BCR mediated activation.
Ligand/Receptor: Galectin-1, CD2, CD3, and CD4.
Cell Type: B cells, Dendritic cells, Neutrophils
Biology Area: Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family: CD Molecules, Protein Kinases/Phosphatase, TCRs
Antigen References: 1. Thomas M. 1989. Annu. Rev. Immunol. 7:339. 2. Trowbridge I, et al. 1994. Annu. Rev. Immunol. 12:85.
Gene ID: 5788
UniProt: View information about CD45 on UniProt.org
Clone: 2D1
Regulatory Status: RUO
Other Names: Leukocyte Common Antigen (LCA), T200
Isotype: Mouse IgG1, κ